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Abstract
The goal of this paper was to determine the contribution of the mitochondrial branched chain aminotransferase (BCATm)
to branched chain K-keto acid transport within rat heart mitochondria. Isolated heart mitochondria were treated with
sulfhydryl reagents of varying permeability, and the data suggest that essential cysteine residues in BCATm are accessible
from the cytosolic face of the inner membrane. Treatment with 15 nmol/mg N-ethylmaleimide (NEM) inhibited initial rates
of K-ketoisocaproate (KIC) uptake in reconstituted mitochondrial detergent extracts by 70% and in the intact organelle by
50%. KIC protected against inhibition suggesting that NEM labeled a cysteine residue that is inaccessible when substrate is
bound to the enzyme. Additionally, the apparent mitochondrial equilibrium KIC concentration was decreased 50^60% after
NEM labeling, and this difference could not be attributed to effects of NEM on matrix pH or KIC oxidation. In fact, NEM
was a better inhibitor of KIC oxidation than rotenone. Measuring matrix aspartate and glutamate levels revealed that the
effects of NEM on the steady-state KIC concentration resulted from inhibition of BCATm catalyzed transamination of KIC
with matrix glutamate to form leucine. Furthermore, circular dichroism spectra of recombinant human BCATm with
liposomes showed that the commercial lipids used in the reconstituted transport assay contain BCAT amino acid substrates.
Thus BCATm is distinct from the branched chain K-keto acid carrier but may interact with the inner mitochondrial
membrane, and it is necessary to inhibit or remove transaminase activity in both intact and reconstituted systems prior to
quantifying transport of K-keto acids which are transaminase substrates. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The ¢rst step in the catabolism of the essential
amino acids, leucine, valine, and isoleucine, is trans-
amination to their respective branched chain K-keto
acids. The transport of these metabolites across the
inner mitochondrial membrane is catalyzed by the
branched chain K-keto acid transporter which has
been characterized kinetically in rat heart mitochon-
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Abbreviations: BCATm, mitochondrial branched chain amino-
transferase; BCAT, branched chain aminotransferase; KIC, K-
ketoisocaproate; NEM, N-ethylmaleimide; mersalyl, O-(3-hydro-
xymercuri-2-methoxypropyl)carbamylphenoxyacetate ; pCMB, p-
chloromercuribenzoate; pCMBS, p-chloromercuribenzene sulfo-
nate; DTT, dithiothreitol ; CHAPS, 3-[(3-cholamidopropyl)di-
methylammonio]-1-propanesulfonate; MOPS, 3-(N-morpholino)-
propanesulfonate; AOA, amino-oxyacetate
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dria [1,2]. The substrate speci¢city of the exchange
reaction and pH dependence suggest that the
branched chain K-keto acid carrier is distinct from
the pyruvate transporter; nevertheless, both carriers
appear to catalyze uptake of their respective mono-
carboxylic acids via a proton symport mechanism
[1,3]. Subsequently, the branched chain K-keto acid
transporter was solubilized in functionally active
form from rat heart mitochondria and shown to be
sensitive to sulfhydryl reagents [4]. Evidence was pre-
sented [5] suggesting that BCATm could be the
branched chain K-keto acid transporter characterized
previously [1]; however, it remains to be established
whether BCATm actually functions as a transporter
in intact heart mitochondria.
Organic mercurials and maleimides have been the
most common reagents employed to characterize mi-
tochondrial anion carriers both in situ [6^14] and
using recombinant transport proteins in reconstitu-
tion systems [15^22]. The e¡ects of these reagents
on transporter function have suggested that cysteine
residues are important for these proteins, hypotheses
which have been addressed through site-directed mu-
tagenesis [19,23^26]. With the recent availability of
the complete yeast genome sequence, genetic and
biochemical approaches continue to be used to iden-
tify new members of the mitochondrial carrier super-
family [27^31]. Although recent evidence suggests the
existence of a mitochondrial translocase for acylcar-
nitine intermediates derived from branched chain
amino acid oxidation [32], the transport proteins
for branched chain K-keto acids and pyruvate have
not been reported for either yeast or mammalian
systems. Therefore, we utilized the availability of re-
combinant BCATm [33] and its sensitivity to sulf-
hydryl reagents [5,34] to assess the possible role of
this protein in mitochondrial branched chain K-keto
acid transport.
2. Materials and methods
2.1. Preparation of mitochondria
Rat heart [35] and liver [36] mitochondria were
prepared from male Sprague^Dawley rats (250^
300 g) using mannitol sucrose isolation medium
(0.225 M mannitol, 0.075 M sucrose, 5 mM
MOPS, 0.1 mM EDTA, pH 7.0). Respiratory control
ratios were measured using glutamate and malate as
substrates as described by Hutson et al. [37], and no
preparations with a ratio of 6 6 were used. Protein
was determined by the biuret reaction in the presence
of 0.25% sodium deoxycholate using crystalline bo-
vine albumin as a standard.
2.2. Incubation of mitochondria with sulfhydryl
reagents
All incubations and washes were performed with
mannitol sucrose isolation medium. Freshly prepared
heart or liver mitochondria (20 mg/ml) were incu-
bated with sulfhydryl reagents at 4‡C for 15 min.
After incubation with NEM, the reaction was termi-
nated by the addition of a 10-fold excess of DTT,
and diluted 40-fold with isolation medium containing
3 mM DTT. The mitochondrial solution was centri-
fuged at 8000Ug for 10 min, washed twice, and re-
suspended at a concentration of 20 mg protein/ml.
After incubation with pCMB, pCMBS, or mersalyl,
mitochondria were diluted 40-fold with isolation me-
dium and washed twice. In some experiments, K-ke-
toisocaproate (KIC, 2 mM) was added 5 min before
NEM. Control incubations were conducted under
identical conditions in the absence of sulfhydryl re-
agents.
2.3. Measurement of mitochondrial metabolites
Rat heart mitochondria were extracted either with
2% sulfosalicylic acid and assayed for glutathione
using the recycling assay essentially as described by
Tietze [38] or with 2% perchloric acid and assayed
for aspartate, glutamate, and K-ketoglutarate using
standard £uorimetric methods [39,40]. NADH £uo-
rescence (excitation: 340 nm, emission: 465 nm) was
monitored using an Aminco Bowman Series 2 lumi-
nescence spectrometer (Spectronic Instruments, Ro-
chester, NY).
2.4. Measurement of K-keto acid transport in intact
mitochondria and determination of
intramitochondrial pH
Uptake of K-keto acids into heart or liver mito-
chondria was measured at 8‡C as described previ-
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ously [1,2]. Brie£y, an aliquot of mitochondria was
added to a chamber containing 140 mM KCl, 20
mM MOPS (pH 7, 8‡C), 10 mM succinate, 12 WM
rotenone, 7% dextran, and [1-14C]sucrose or 3H2O.
At selected times, samples were taken, and the mito-
chondria were separated from the media by rapid
centrifugation through silicone oil (83.5 parts Dow
Corning 550 and 16.5 parts Dow Corning 200).
Rates of transport were calculated by determining
the initial rate of K-keto acid uptake. Alternatively,
transport rates were calculated assuming a ¢rst order
approach to a ¢nal equilibrium value for the internal
K-keto acid concentration [2,41]. With this method
[41], ln([At]/([At]3[Ai])) is plotted versus time where
[At] is the internal concentration of K-keto acid at
steady state and [Ai] is the internal concentration at
time t. The ¢rst order rate constant for e¥ux, k, is
the slope of this line. Since at steady state K-keto
acid e¥ux is equal to uptake, the rate of K-keto
acid transport can be calculated using the following
equation: v = k[At]. It is assumed that the rate of
uptake is constant over time and e¥ux is ¢rst order.
Matrix pH was determined using the weak acid
5,5P-dimethyl[2-14C]oxazolidine-2,4-dione as de-
scribed [2], and matrix water was determined using
3H2O and [1-14C]sucrose. Measurements of mito-
chondrial pH were made in samples of mitochondria
incubated under the same experimental conditions as
in the transport or labeling experiments.
2.5. Solubilization of the mitochondria and
reconstitution of K-keto acid transport activity
Mitochondria (approximately 40^45 mg protein)
were extracted with 1% Triton X-114 as described
previously [4] without addition of KIC or cardioli-
pin. Phospholipid vesicles were prepared as described
[4,42] except vesicles were formed by sonication using
a Branson Soni¢er 250 (Branson Ultrasonics, Dan-
bury CT) at an output setting of 1.6^2 and a duty
cycle of 70^90%. Depending on the volume of
vesicles required, either a 0.5-inch diameter disruptor
horn with £at tip or a double stepped microtip was
used. Resuspended lipids were placed on ice and so-
nicated 3^5 min then allowed to cool for 1^2 min.
These steps were repeated until the lipid suspension
cleared (V10^20 min). Then proteoliposomes were
formed by adding aliquots of the Triton X-114 mi-
tochondrial extract to the phospholipid vesicles fol-
lowed by freeze^thaw sonication [4,42]. In a previous
description of this procedure [4], detergent extraction
was carried out in the presence of KIC. Subse-
quently, the proteoliposomes were passed over Dow-
ex-1(X8) anion exchange resin to remove excess KIC
prior to use in the transport assay. For the experi-
ments presented in this paper, KIC was not included
in the extraction, thus the proteoliposomes were not
subjected to Dowex resin treatment prior to measur-
ing KIC transport. pCMB sensitive [1-14C]KIC and
[1-14C]pyruvate transport activities were measured as
described [4,5]. The sulfhydryl reagent pCMB was
also used as an inhibitor stop for pyruvate, because
previous studies demonstrated that it was more e¡ec-
tive than the noncompetitive pyruvate transport in-
hibitor K-cyano-3-hydroxycinnamic acid [43]. Ali-
quots of each reaction mixture were placed on
separate Dowex-1(X8) columns; the liposomes were
eluted, and radioactivity was quanti¢ed as described
[4,42]. In the detergent extracts, protein was mea-
sured using the Bio-Rad assay (Bio-Rad Laborato-
ries, Hercules, CA).
2.6. Measurement of K-keto acid oxidative
decarboxylation under transport assay conditions
Oxidative decarboxylation of [1-14C]KIC or [1-14C]-
pyruvate was measured in the transport bu¡er at
8‡C as described by Hutson et al. [37] except 14CO2
was trapped with 0.25 ml tissue solubilizer (DuPont/
NEN, Wilmington, DE). Data were corrected for
the e⁄ciency of the CO2 trap with an average recov-
ery of 85%.
2.7. Determination of branched-chain
aminotransferase activity
Mitochondrial branched-chain aminotransferase
activity was measured at 37‡C as described previ-
ously [43]. The ¢nal assay mixture contained 50 mM
potassium phosphate bu¡er, pH 7.8 (KOH), 50 WM
pyridoxal phosphate, 0.4% CHAPS, 2 mM DTT,
1 mM K-[1-14C]ketoisovalerate, and 12 mM isoleu-
cine. CHAPS was not added in assays of Triton
X-114 mitochondrial extracts, and DTT was omitted
from the samples and control assays for all sulfhy-
dryl reagents except NEM.
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2.8. Lipid extraction and thin-layer chromatography
3-sn-Phosphatidylcholine from either dried egg
yolk or soybean (Fluka, Ronkonkoma, NY) was sus-
pended in H2O at 50 mg lipid/ml, sonicated to form
liposomes, and extracted using the method of Bligh
and Dyer [44]. After centrifugation, the aqueous
phase was removed, dried under vacuum, and resus-
pended in 10% methanol. Samples, amino acids, and
phospholipid standards were applied to Silica Gel G
plates (20U20 cm, Analtech, Newark, DE) and de-
veloped in either chloroform/methanol/ammonium
hydroxide (2:2:1, v/v) or methylethylketone/pyri-
dine/H2O/glacial acetic acid (70:15:15:2, v/v) [45].
Plates were air dried at room temperature v 1 h,
and amino acids were visualized with ninhydrin
(88% acetone, 2% acetic acid, 0.2% ninhydrin, 0.1%
cadmium acetate). Plates were also sprayed with a
55% sulfuric acid solution containing 0.6% (w/v) po-
tassium dichromate, and phospholipids were visual-
ized by charring.
2.9. Circular dichroism spectroscopy
Near UV circular dichroism spectroscopy was per-
formed as described previously [33] with recombinant
human BCATm in the absence and presence of phos-
phatidylcholine liposomes. The enzyme was con-
verted to the pyridoxal phosphate form by incuba-
tion with 1 mM KIC for 1 h or to the pyridoxamine
phosphate form by incubation with 5 mM leucine for
1 h followed by dialysis to remove substrate [33].
Liposomes were formed by sonication as described
above, and the ¢nal solution (1 ml) contained 10 mM
Hepes (pH 7.5), 150 mM NaCl, 1 mM DTT, 5 mg/ml
lipid, and 0.3 mg recombinant human BCATm.
2.10. Statistical analysis
Statistical analysis was performed using a two-
tailed Student’s t-test. Signi¢cance was reached at
P6 0.005.
2.11. Chemicals and reagents
L-[1-14C]Leucine was obtained from either Amer-
sham Pharmacia Biotech (Piscataway, NJ) or Du-
Pont/NEN (Wilmington, DE). L-[1-14C]Valine was
obtained from American Radiolabeled Chemicals
(St. Louis, MO). Radiolabeled KIC and K-ketoiso-
valerate were synthesized from leucine and valine,
respectively, essentially as described by Ru«diger
[46]. 5,5P-Dimethyl[2-14C]oxazolidine-2,4-dione was
obtained from Amersham Pharmacia Biotech.
NEM, pCMB, pCMBS, and mersalyl were obtained
from Sigma (St. Louis, MO). AOA was obtained
from Aldrich (Milwaukee, WI). Pure 3-sn-phosphati-
dylcholine was obtained from Avanti Polar Lipids
(Alabaster, AL).
3. Results and discussion
3.1. E¡ect of sulfhydryl reagents on transamination
and KIC transport
To better de¢ne the localization of BCATm in
mitochondria and to determine its actual contribu-
tion to mitochondrial branched chain K-keto acid
transport, intact rat heart mitochondria were incu-
bated with permeable and impermeable sulfhydryl
reagents. Then the mitochondria were extracted
with detergent, BCAT activity was measured in the
extracts and KIC transport activity was measured
after reconstitution in proteoliposomes (Table 1).
NEM was the most e¡ective reagent with 80% inhi-
bition of aminotransferase and transport activities
observed at a concentration of 15 nmol/mg mito-
chondrial protein (Table 1). Similar concentrations
of mersalyl and pCMB also inhibited both activities
by 60^70% whereas a higher concentration of
pCMBS (100 nmol/mg mitochondrial protein) was
required to achieve the same degree of inhibition.
With the exception of the polar pCMBS, both en-
zyme activities were inhibited in parallel, and
pCMBS appeared to have a signi¢cantly greater ef-
fect on transport activity than on transaminase ac-
tivity (P6 0.005).
As also shown in Table 1, measurements of total
mitochondrial glutathione con¢rmed that only NEM
was freely permeable to the inner mitochondrial
membrane. Reports with liver [47] and heart [48]
mitochondria have shown previously that the mercu-
rial reagents, pCMB, pCMBS, and mersalyl, are gen-
erally considered impermeable. Addition of DTT to
the reaction mixtures did not a¡ect changes in glu-
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tathione levels but reversed the inhibition by pCMB,
pCMBS, and mersalyl restoring BCAT activity to
v90% of control values (data not shown). Therefore,
the results suggested that the reactive SH group(s) in
BCATm was accessible from the cytosolic side of the
inner mitochondrial membrane, and that both trans-
port and transaminase activities were a¡ected by
these reagents.
Next, NEM (15 nmol/mg) was used to determine
the e¡ect of inhibiting BCATm on the kinetics of
KIC uptake in isolated rat heart mitochondria, and
the results were compared with liver mitochondria
which do not contain BCATm [49]. At this concen-
tration of NEM, only the phosphate carrier should
be a¡ected [8] whereas the pyruvate, dicarboxylate,
tricarboxylate, and K-ketoglutarate carriers would
not be inhibited [47,50]. Pyruvate uptake, which
should not be a¡ected by this concentration of
NEM [50], was also measured in selected experi-
ments. Table 2 shows the e¡ect of NEM on initial
rates of KIC uptake in intact mitochondria and after
detergent extraction of the mitochondria and recon-
Table 2
Summary of NEM inhibition of the initial rates of K-keto acid transport in heart and liver mitochondria and a reconstituted system
Mitochondria Monocarboxylate transport
Isolated mitochondria (% control) Reconstitution system (% control)
Pyruvate KIC Pyruvate KIC
Heart
Control 100 100 100 100
NEM 93 þ 3 48 þ 3 108 þ 9 29 þ 4
KIC+NEM NDa 75 þ 4 ND 73 þ 10
Liver
Control 100 100 ^ ^
NEM 101 þ 1 125 þ 8 ^ ^
Freshly isolated mitochondria were incubated with NEM (15 nmol/mg) and either used to determine K-keto acid uptake or extracted
with detergent as described in Section 2. KIC and pyruvate concentrations ranged from 20 to 100 WM. The results are the mean þ S.E.
for 3^6 mitochondrial preparations.
aND, not determined.
Table 1
E¡ect of sulfhydryl reagents on rat heart mitochondrial BCATm activity, reconstituted KIC transport activity, and total glutathione
content
-3SH Reagent Mitochondrial detergent extracts
BCAT activity (% control) KIC transport (% control) Total glutathione (% control)
NEM 19 þ 1 20 þ 3 7 þ 1
Mersalyl 28 þ 1a 24 þ 0.4a 101 þ 5
pCMB 39 þ 1b 30 þ 2b 92 þ 9
pCMBS 36 þ 4c 22 þ 3c 88 þ 3
Preparation of mitochondria, incubation with sulfhydryl reagents, extraction procedures, and measurement of BCAT, reconstituted
KIC transport activity and glutathione content are described in Section 2. For NEM, the average and range of two mitochondrial
preparations, one with triplicate and one with quadruplicate samples, are shown. Values for mersalyl are means þ S.D. from quadru-
plicate samples in one mitochondrial preparation. For pCMB and pCMBS, means þ S.E. are presented from three mitochondrial prep-
arations. Control transaminase and KIC transport activities were 127 þ 24 (n = 9) and 3 þ 0.3 (n = 9) nmol/min per mg mitochondrial
protein, respectively. Values for glutathione are the mean þ S.E. from 3^5 mitochondrial preparations. Control preparations contained
5.9 þ 0.3 (n = 8) nmol glutathione/mg mitochondrial protein.
a25 nmol/mg mitochondrial protein.
b10 nmol/mg mitochondrial protein.
c100 nmol/mg mitochondrial protein
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stitution of transport activity in proteoliposomes. In-
itial rates of pyruvate uptake in liver and heart mi-
tochondria were una¡ected by NEM treatment,
whereas initial rates of KIC uptake in liver mito-
chondria were increased after NEM treatment (Table
2). We have also observed that addition of NEM
(20^50 nmol/mg protein) directly to the transport
assay stimulated the rate of K-ketoisovalerate uptake
in liver mitochondria preparations by 16^57% (data
not shown). In heart mitochondria, initial rates of
KIC uptake were inhibited 50% by NEM treatment,
and addition of KIC before NEM provided substan-
tial protection against inhibition (Table 2). These
results were consistent with the idea that BCATm
plays a role in KIC transport in situ.
As suggested by the time course of KIC uptake
with and without NEM (Fig. 1), NEM appeared to
a¡ect not only the initial rate of uptake but also the
steady-state level of KIC ([KICt]). The data were ¢t
to the equation ln([At]/([At]3[Ai])) = kt, and the rate
of K-keto acid uptake was calculated using the equa-
tion v = k[At] [41]. Inhibition of KIC uptake by NEM
would be expected to lower the amount of active
transporter resulting in a lowered rate of KIC up-
take, a longer time to reach equilibrium, and a lower
Vmax, but would not be expected to a¡ect [KICt],
which is dependent on the vpH across the inner mi-
tochondrial membrane. Nonetheless, calculated and
observed [KICt] values were decreased approximately
50% compared with untreated controls (Fig. 1). Ta-
ble 3 shows the ratios of the mean equilibrium KIC
and pyruvate concentrations in NEM-treated heart
and liver mitochondria compared with control mito-
chondria. The ratios of mean steady-state pyruvate
concentrations were similar in both types of mito-
chondria, whereas the [KICt] ratio was signi¢cantly
higher than 1.0 in liver and lower than 1.0 in heart
(P6 0.005). Because the steady-state distribution of
the KIC anion should be proportional to the pH
gradient, the vpH was measured in the control and
NEM-treated mitochondria (Table 3). Although
heart mitochondria respiring on succinate maintain
a signi¢cantly higher vpH than liver mitochondria
respiring on succinate [2], the experimentally deter-
mined matrix pH during the transport experiments
was comparable in control and NEM-treated mito-
chondria (Table 3). Moreover, the similarity in the
ratio of steady-state pyruvate concentrations in con-
trol and NEM-treated heart and liver mitochondria
is consistent with the lack of change in vpH.
Di¡erences in the uptake curves could also result
from metabolism of the K-keto acids. Because a spe-
ci¢c inhibitor of the branched chain K-keto acid de-
hydrogenase enzyme complex is not available, me-
tabolism of the K-keto acids was blocked by
conducting the experiments at 8‡C in the presence
of rotenone which blocks oxidation of NADH, a
product of branched chain K-keto acid oxidative de-
carboxylation. Direct measurement of [1-14C]KIC
(30 WM) oxidation in the transport bu¡er was
0.75 þ 0.21 nmol/mg protein per 10 min in heart
(n = 5) and 0.83 þ 0.15 nmol/mg protein/10 min in
liver (n = 4), which indicated that rotenone alone is
Fig. 1. E¡ect of NEM treatment on the time course of K-keto-
isocaproate (KIC) uptake in isolated heart mitochondria.
Freshly isolated mitochondria were treated with NEM (15 nmol/
mg protein), and mitochondrial uptake of [1-14C]KIC was mea-
sured at 8‡C as described in Section 2. The medium pH was
7.1. Calculated kefflux and steady-state matrix KIC concentra-
tions ([KICt]) were: control (R), 0.18 min31 and 1.52 nmol/mg
protein; NEM treated (O), 0.29 min31 and 0.71 nmol/mg pro-
tein; control (b), 0.22 min31 and 4.48 nmol/mg protein; NEM
treated (a), 0.38 min31 and 1.64 nmol/mg protein. KIC concen-
trations are shown in the ¢gure.
BBAMEM 77926 22-9-00
P.M. Drown et al. / Biochimica et Biophysica Acta 1468 (2000) 273^284278
not su⁄cient to block KIC metabolism. However,
KIC oxidation was depressed in NEM-treated heart
and liver mitochondria to 0.11 þ 0.04 nmol/mg pro-
tein per 10 min (n = 5) and 0.12 þ 0.04 nmol/mg pro-
tein per 10 min (n = 4), respectively. Sensitivity to
sulfhydryl reagents has been reported for the
branched chain K-keto acid dehydrogenase enzyme
complex [51]; therefore, NEM inhibition of KIC oxi-
dation in liver would be consistent with the higher
[KICt] values (Table 3) and the increased initial rates
of KIC uptake (Table 2) observed after NEM treat-
ment of liver mitochondria. However, this would not
explain the lower equilibrium KIC concentration
found in heart mitochondria. Since BCATm is not
present in liver but is found in heart, the higher
[KICt] seen in control heart mitochondria could re-
sult from conversion of KIC to leucine which is sub-
sequently trapped in the matrix in the absence of an
exchangeable amino acid. Bachowska-Mac et al. [52]
have shown that transamination was the driving
force for KIC uptake across the plasma membrane
of neuroblastoma cells, and it has been suggested
that neutral amino acid transport in liver mitochon-
dria occurs through an exchange mechanism [53,54].
To test this possibility, heart mitochondrial aspartate
and glutamate concentrations were measured under
the conditions used in the uptake assay. KIC trans-
amination with glutamate would be expected to stim-
ulate conversion of glutamate to K-ketoglutarate in
the mitochondrial matrix. Addition of KIC to con-
trol mitochondria lowered matrix aspartate levels 30^
40% whereas glutamate levels were una¡ected, sug-
gesting that KIC transamination with glutamate
shifts the aspartate aminotransferase reaction toward
the utilization of aspartate and the production of
glutamate. Addition of KIC to NEM-treated mito-
chondria did not a¡ect matrix glutamate or aspartate
levels; therefore, it appears that BCATm-catalyzed
transamination of KIC to leucine is occurring in con-
trol mitochondria and that the radioactive leucine
remains in the matrix. Thus, the assumption that
v = k[At] is incorrect, because [KICt] is overestimated.
These results explain the apparent decrease in the
equilibrium KIC concentration after NEM treatment
and suggest that KIC transport measured after the
inhibition of BCATm by NEM more accurately re-
£ects the actual branched chain K-keto acid carrier
activity.
3.2. Analysis of lipids used for reconstitution of
KIC transport
The time course results obtained with isolated mi-
tochondria may be explained if BCATm was catalyz-
ing transamination of matrix KIC with endogenous
mitochondrial substrates; however, reconstituted
KIC transport activity was also inhibited by NEM
(Tables 1 and 2). Therefore, we investigated the pos-
sibility that transamination was occurring in the pro-
teoliposomes. Intact mitochondria as well as recon-
stituted mitochondrial detergent extracts contain
numerous proteins other than BCATm that may
have an e¡ect on measured branched chain K-keto
acid transport; therefore, to simplify the system, pu-
Table 3
In£uence on NEM on calculated equilibrium matrix K-keto acid concentration and matrix pH in intact mitochondria
[KICt] ratio in NEM-labeled vs. control mitochondria Matrix pH
Control NEM
Heart mitochondria 8.78 þ 0.06 8.84 þ 0.09
KIC 0.50 þ 0.05a
Pyruvate 1.17 þ 0.11
Liver mitochondria 8.47 þ 0.03 8.50 þ 0.03
KIC 1.94 þ 0.26a
Pyruvate 1.14 þ 0.07
Heart and liver mitochondria were prepared and treated with NEM, KIC uptake was measured, and equilibrium matrix concentra-
tions of KIC ([KICt]) and pyruvate were calculated as described in Section 2. Matrix pH was measured using 5,5P-dimethyl oxazoli-
dine-2,4-dione [2], and medium pH was 7.08. Matrix H2O was the same in control and NEM samples, and the mean value was
0.93 þ 0.03 Wl/mg mitochondrial protein. KIC was 30 WM, and pyruvate was 100 WM. Means þ S.E. from 4^8 experiments are shown.
aP6 0.005.
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ri¢ed recombinant human BCATm was used. This
enzyme has been cloned, overexpressed, and charac-
terized [33]. An amino acid sequence comparison [55]
shows that rat and human BCATm are 82% identi-
cal, and like the rat enzyme [34], human BCATm is
inhibited 79 þ 2% (n = 4) by 1 mM NEM. Addition-
ally, human BCATm appears to catalyze KIC trans-
port when added to egg yolk liposomes. The appar-
ent rate of KIC uptake (100 WM KIC) was 4 þ 0.5
Wmol/min per mg protein (n = 12).
BCATm is a ping-pong enzyme and contains pyr-
idoxal-5P-phosphate as a cofactor which alternates
between two forms, the pyridoxal and the pyridox-
amine form [56]. Addition of an amino acid substrate
results in the formation of an external aldimine-ami-
no acid-pyridoxal phosphate complex which is then
converted to the pyridoxamine form of the cofactor
and K-keto acid product. This process is reversible in
the presence of a second K-keto acid substrate which
converts the cofactor back to its pyridoxal form pro-
ducing the corresponding amino acid. Circular di-
chroism spectroscopy was used to determine whether
or not there were changes in protein conformation or
form of the enzyme cofactor in recombinant human
BCATm when added to liposomes. Human BCATm
was converted to the pyridoxal form of the cofactor,
and the spectrum is shown by the dotted line in Fig.
2A. This form is characterized by a strong peak of
ellipticity at 421 nm and weaker ellipticity at 277 nm
[33]. The enzyme was also converted to the pyridox-
amine form as shown by the solid line in Fig. 2A.
This form exhibits weak ellipticity at 326 nm and a
strong peak of ellipticity at 277 nm [33]. Addition of
the pyridoxal form of BCATm to egg yolk liposomes
resulted in conversion of approximately 60% of the
enzyme to the pyridoxamine form (Fig. 2B) as sug-
gested by the disappearance of ellipticity at 421 nm,
the appearance of a weaker peak at 326 nm, and an
increase in ellipticity around 277 nm [33]. However,
no spectral changes were seen with vesicles from ei-
ther puri¢ed phosphatidylcholine (data not shown)
or crude phosphatidylcholine from soybean (Fig.
2C). These results suggested that a substrate amino
acid was present in the egg yolk lipids.
To characterize possible endogenous amino acids
in the commercial lipid, the egg yolk and soybean
lipids were extracted with methanol and chloroform
[44]. The aqueous phase of the lipid extracts, which
contained water soluble compounds, was subjected
to thin-layer chromatography. Numerous amine con-
taining compounds from both the egg yolk and soy-
bean lipids co-migrated with the amino acid stan-
dards (Fig. 3A); however, fewer compounds were
seen in the soybean sample. Egg yolk phosphatidyl-
choline appeared to contain isoleucine and leucine
(Fig. 3A); however, the hydrophobic amino acid
Fig. 2. Near UV circular dichroism spectroscopy of human
BCATm in phosphatidylcholine liposomes. Samples were pre-
pared as described in Section 2. The pyridoxal and pyridox-
amine phosphate forms of human BCATm were prepared by
incubating the enzyme with the appropriate substrate followed
by dialysis. Near UV circular dichroism spectra were measured
in a 1 cm quartz cuvette and are the average of four accumula-
tions. (A) Spectra were taken in the absence of liposomes. The
dotted line represents the pyridoxal phosphate form, and the
solid line represents the pyridoxamine phosphate form of
BCATm. (B,C) The dotted line represents the pyridoxal phos-
phate form in the absence of liposomes, and the solid line rep-
resents the BCATm spectrum in the presence of egg yolk (B) or
soybean (C) liposomes.
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tryptophan migrated along with the branched chain
amino acids when the solvent system was chloro-
form/methanol/ammonium hydroxide. Using a more
hydrophobic solvent system, spots correlating to
both leucine and isoleucine were seen in the egg
yolk lipids but not in the soybean lipids (Fig. 3B).
A spot that appeared to co-migrate with the gluta-
mate standard was found in the egg yolk lipids de-
veloped in the hydrophobic solvent system (Fig. 3B)
but not in the more hydrophilic system (Fig. 3A).
Quantifying radiolabeled glutamate added to the lip-
ids prior to extraction revealed that 6 3% parti-
tioned in the lipid phase. Because the lipids are pre-
pared commercially by organic extraction, it is
unlikely that glutamate was present; however, these
results indicate that hydrophobic amino acids, such
as the branched chain amino acids or alanine, may
be present in the phospholipids used routinely for
mitochondrial transporter reconstitution (for review
see [57]).
This conclusion is supported by activity measure-
ments using human BCATm reconstituted in egg
yolk, soybean, and puri¢ed phosphatidylcholine lip-
ids. KIC transport and transamination were com-
pared in the absence and presence of either NEM
or the general transaminase inhibitor, amino-oxy-
acetate (AOA). Because the speci¢c activity of the
enzyme is dependent on both the amount of KIC
added and the concentration of amino acid in the
liposomes, both activities were measured under iden-
tical conditions, and NEM or AOA (1 mM) was
added 5 min before addition of radiolabeled KIC.
Both KIC transport and transamination were similar
in egg yolk lipids, 3.00 þ 0.01 (n = 2) and 4.0 þ 0.1
(n = 2) Wmol/min per mg, respectively, and both ac-
tivities were inhibited 88^89% by NEM. AOA inhi-
bition could not be measured in the transaminase
assay, because the reagent is known to form an ad-
duct with KIC in the presence of acid which cannot
be decarboxylated [43]; however, KIC transport in
the egg yolk lipids was decreased s 99% after incu-
bation with AOA. Finally, in soybean and puri¢ed
phosphatidylcholine lipids, both transport and trans-
amination were 6 1% of the activity seen with egg
yolk lipids. These results indicate that transamina-
tion can occur in the reconstituted KIC transport
assay and further support the conclusion that amino
Fig. 3. Thin-layer chromatography of the aqueous layer from
egg yolk and soybean liposome extracts. Egg yolk and soybean
liposomes were prepared and extracted as described in Section
2. Amino acid standards are listed along with the phospholipid
standards phosphatidylcholine (PC) and phosphatidylethanol-
amine (PE). Various amino acids are highlighted with arrows.
On the left side, amino acids were visualized with ninhydrin
spray, and on the right side, phospholipids were sprayed with a
sulfuric acid solution and charred. (A) Plate was developed in
chloroform/methanol/ammonium hydroxide (2:2:1, v/v) for 45
min. (B) Plate was developed in methylethylketone/pyridine/
H2O/acetic acid (70:15:15:2, v/v) for 65 min.
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acid substrates are present in commercial prepara-
tions of the egg yolk lipids.
4. Conclusions
The goal of this paper was to determine the con-
tribution of BCATm to mitochondrial branched
chain K-keto acid transport. Analysis of KIC uptake
in isolated mitochondria showed that BCATm uti-
lization of endogenous mitochondrial substrates al-
tered apparent equilibrium concentrations of KIC,
and the enzyme’s reaction with endogenous sub-
strates in commercial lipid preparations could be
monitored by CD spectroscopy. Moreover, apparent
reconstituted KIC transport was decreased s 99%
by the transaminase inhibitor, AOA. These results
indicate that BCATm-catalyzed transamination can
a¡ect transport measurements and that BCATm and
the branched chain K-keto acid carrier are separate
proteins. Therefore, transaminase activity must be
inhibited when measuring transport of potential K-
keto acid substrates in either intact organelles, such
as mitochondria, yeast, or cell lines, or in reconstitu-
tion systems. In lieu of an enzyme speci¢c inhibitor,
AOA may be a useful reagent in these types of ex-
periments. Addition of this compound to heart mi-
tochondria reduced BCATm-catalyzed transamina-
tion to below detectable levels without a¡ecting
branched chain K-keto acid oxidation [43]. Thus,
this inhibitor appears not to a¡ect transport and
may be e¡ective in studies of other K-keto acid car-
riers such as the pyruvate transporter in intact sys-
tems.
The presence of amino acid substrates in commer-
cial lipid preparations also provides an explanation
for previous results obtained with mitochondrial ex-
tracts. The described procedure [4] for detergent ex-
traction of the branched chain K-keto acid transport-
er from mitochondria used 5 mM KIC in the
extraction bu¡er and soybean lipids for reconstitu-
tion of KIC transport activity in proteoliposomes.
Subsequently, the proteoliposomes were passed over
Dowex anion exchange resin to remove excess KIC
prior to use in the transport assay [4]. This step
would also tend to remove BCATm from the proteo-
liposomes, since the enzyme is an anion at neutral
pH. This procedure was later modi¢ed such that the
Dowex resin step was omitted, and activity was re-
constituted in egg yolk lipids resulting in a v10-fold
increase in apparent KIC transport [5]. This result
may now be explained by the presence of BCATm
and amino acid substrates in the egg yolk lipid sam-
ples. Additionally, transport and transaminase activ-
ities in the proteoliposomes were reduced 80^90%
after one passage over the anion exchange resin,
and the resulting KIC transport activity (0.5 nmol/
min per mg mitochondrial protein) was comparable
to that observed in either NEM or AOA-treated mi-
tochondria (0.6^0.7 nmol KIC/min per mg protein).
Thus, various chromatographic methods such as ion
exchange over Dowex or Amberlite resin also may be
e¡ective tools in removing unwanted enzyme activ-
ities from reconstitution mixtures.
Finally, the inhibition of BCATm within the intact
mitochondria after treatment with impermeable sulf-
hydryl reagents is an intriguing result. Analysis of
the primary sequence of rat or human BCATm
with the PSORT II program [58,59] to detect trans-
membrane segments predicts only one potential
membrane spanning region within the BCATm
monomer. Therefore, one may speculate that
BCATm loosely associates with the inner mitochon-
drial membrane or is bound to a second membrane
anchored protein which permits labeling of reactive
cysteine residues within BCATm from the cytosolic
face of the inner mitochondrial membrane. This phe-
nomenon has been reported for the mitochondrial
aspartate aminotransferase which has been shown
to bind to inverted mitochondrial inner membrane
vesicles [60,61] possibly via a second membrane an-
choring protein [62] ; however, further studies have
not been reported. Thus, additional experimental ap-
proaches will be required to determine the precise
mitochondrial localization of BCATm.
Acknowledgements
This research was supported by Grant DK34378
(to S.M.H.) from The National Institutes of Health,
United States Public Health Service.
BBAMEM 77926 22-9-00
P.M. Drown et al. / Biochimica et Biophysica Acta 1468 (2000) 273^284282
References
[1] S.M. Hutson, S.L. Rannels, J. Biol. Chem. 260 (1985)
14189^14193.
[2] S.M. Hutson, J. Biol. Chem. 262 (1987) 9629^9635.
[3] A.P. Halestrap, R.M. Denton, Biochem. J. 148 (1975) 97^
106.
[4] S.M. Hutson, S. Roten, R.S. Kaplan, Proc. Natl. Acad. Sci.
USA 87 (1990) 1028^1031.
[5] S.M. Hutson, T.R. Hall, J. Biol. Chem. 268 (1993) 3084^
3091.
[6] J. Bryla, Pharmacol. Ther. 10 (1980) 351^397.
[7] A.J. Meijer, G.S.P. Groot, J.M. Tager, FEBS Lett. 8 (1970)
41^44.
[8] W.A. Coty, P.L. Pedersen, Mol. Cell. Biochem. 9 (1975)
109^124.
[9] J. Hous›te›k, P.L. Pedersen, J. Biol. Chem. 260 (1985) 6288^
6295.
[10] T. Dierks, A. Salentin, C. Heberger, R. Kra«mer, Biochim.
Biophys. Acta 1028 (1990) 268^280.
[11] T. Dierks, A. Salentin, R. Kra«mer, Biochim. Biophys. Acta
1028 (1990) 281^288.
[12] E. Rial, I. Are'chaga, E. Sainz-de-la-maza, D.G. Nicholls,
Eur. J. Biochem. 182 (1989) 187^193.
[13] P. Jez›ek, Z. Drahota, Eur. J. Biochem. 183 (1989) 89^95.
[14] P. Jez›ek, FEBS Lett. 211 (1987) 89^93.
[15] A. Schroers, A. Burkovski, H. Wohlrab, R. Kra«mer, J. Biol.
Chem. 273 (1998) 14269^14276.
[16] G. Fiermonte, V. Dolce, F. Palmieri, J. Biol. Chem. 273
(1998) 22782^22787.
[17] G. Fiermonte, L. Palmieri, V. Dolce, F.M. Lasorsa, F. Pal-
mieri, M.J. Runswick, J.E. Walker, J. Biol. Chem. 273
(1998) 24754^24759.
[18] G. Fiermonte, J.E. Walker, F. Palmieri, Biochem. J. 294
(1993) 293^299.
[19] H. Wohlrab, C. Briggs, Biochemistry 33 (1994) 9371^9375.
[20] R.S. Kaplan, J.A. Mayor, D.A. Gremse, D.O. Wood, J. Biol.
Chem. 270 (1995) 4108^4114.
[21] Y. Xu, J.A. Mayor, D. Gremse, D.O. Wood, R.S. Kaplan,
Biochem. Biophys. Res. Commun. 207 (1995) 783^789.
[22] J.A. Mayor, D. Kakhniashvili, D.A. Gremse, C. Campbell,
R. Kra«mer, A. Schroers, R.S. Kaplan, J. Bioenerg. Bio-
membr. 29 (1997) 541^547.
[23] I. Are'chaga, S. Raimbault, S. Prieto, C. Levi-Meyrueis, P.
Saragoza, B. Miroux, D. Ricquier, F. Bouillaud, E. Rial,
Biochem. J. 296 (1993) 639^700.
[24] D.R. Nelson, J.E. Lawson, M. Klingenberg, M.G. Douglas,
J. Mol. Biol. 230 (1993) 1159^1170.
[25] M. Bienengraeber, K.S. Echtay, M. Klingenberg, Biochem-
istry 37 (1998) 3^8.
[26] R. Kotaria, J.A. Mayor, D.E. Walters, R.S. Kaplan, J. Bio-
energ. Biomembr. 31 (1999) 543^549.
[27] L. Palmieri, F.M. Lasorsa, A. De Palma, F. Palmieri, M.J.
Runswick, J.E. Walker, FEBS Lett. 417 (1997) 114^
118.
[28] L. Palmieri, V. De Marco, V. Iacobazzi, F. Palmieri,
M.J. Runswick, J.E. Walker, FEBS Lett. 410 (1997) 447^
451.
[29] L. Palmieri, F. Palmieri, M.J. Runswick, J.E. Walker, FEBS
Lett. 399 (1996) 299^302.
[30] R.S. Kaplan, J.A. Mayor, D. Kakhniashvili, D.A. Gremse,
D.O. Wood, D.R. Nelson, Biochem. Biophys. Res. Com-
mun. 226 (1996) 657^662.
[31] D. Kakhniashvili, J.A. Mayor, D.A. Gremse, Y. Xu, R.S.
Kaplan, J. Biol. Chem. 272 (1997) 4516^4521.
[32] D.S. Roe, C.S. Roe, M. Brivet, L. Sweetman, Mol. Gen.
Met. 69 (2000) 69^75.
[33] J. Davoodi, P.M. Drown, R.K. Bledsoe, R. Wallin, G.D.
Reinhart, S.M. Hutson, J. Biol. Chem. 273 (1998) 4982^
4989.
[34] T.R. Hall, R. Wallin, G.D. Reinhart, S.M. Hutson, J. Biol.
Chem. 268 (1993) 3092^3098.
[35] K.F. LaNoue, F.M.H. Je¡ries, G.K. Radda, Biochemistry
25 (1986) 7667^7675.
[36] W.C. Schneider, G.H. Hogeboom, J. Biol. Chem. 183 (1950)
123^128.
[37] S.M. Hutson, J. Biol. Chem. 261 (1986) 4420^4425.
[38] F. Tietze, Anal. Biochem. 27 (1969) 502^522.
[39] J.R. Williamson, B.E. Corkey, Methods Enzymol. 13 (1969)
434^513.
[40] J.R. Williamson, B.E. Corkey, Methods Enzymol. 55 (1979)
200^222.
[41] K.F. LaNoue, A.C. Schoolwerth, A.J. Pease, J. Biol. Chem.
258 (1983) 1726^1734.
[42] R.S. Kaplan, P.L. Pedersen, J. Biol. Chem. 260 (1985)
10293^10298.
[43] S.M. Hutson, D. Fenstermacher, C. Mahar, J. Biol. Chem.
263 (1988) 3618^3625.
[44] E.G. Bligh, W.J. Dyer, Can. J. Biochem. Physiol. 37 (1959)
911^917.
[45] M. Brenner, A. Niederwieser, Methods Enzymol. 11 (1967)
39^59.
[46] H.W. Ru«diger, U. Langenbeck, H.W. Goedde, Biochem. J.
126 (1972) 445^446.
[47] A. Fonyo¤, J. Bioeng. Biomembr. 10 (1978) 171^194.
[48] E. Ligeti, A. Fonyo¤ , Biochim. Biophys. Acta 973 (1989) 170^
175.
[49] S.M. Hutson, R. Wallin, T.R. Hall, J. Biol. Chem. 267
(1992) 15681^15686.
[50] S. Papa, G. Paradies, Eur. J. Biochem. 49 (1974) 265^274.
[51] N. Nanaumi, Y. Shimomura, M. Suzuki, Biochem. Int. 25
(1991) 137^141.





Biochem. Biophys. Res. Commun. 237 (1997) 63^67.
[53] J. Buchanan, J.R. Popovitch, D.F. Tapley, Biochim. Bio-
phys. Acta 173 (1969) 532^539.
[54] M. King, J.J. Diwan, Arch. Biochem. Biophys. 159 (1973)
166^173.
[55] J. Devereaux, P. Haeberli, O. Smithies, Nucleic Acids Res.
12 (1984) 387^395.
BBAMEM 77926 22-9-00
P.M. Drown et al. / Biochimica et Biophysica Acta 1468 (2000) 273^284 283
[56] J.F. Kirsch, G. Eichele, G.C. Ford, M.G. Vincent, J.N. Jan-
sonius, H. Gehring, P. Christen, J. Mol. Biol. 174 (1984)
497^525.
[57] R. Kra«mer, F. Palmieri, Biochim. Biophys. Acta 974 (1989)
1^23.
[58] P. Klein, M. Kanehisa, C. DeLisi, Biochim. Biophys. Acta
815 (1985) 468^476.
[59] K. Nakai, M. Kanehisa, Genomics 14 (1992) 897^911.
[60] L.A. Fahien, E.H. Kmiotek, G. Woldegiorgis, M. Evenson,
E. Shrago, M. Marshall, J. Biol. Chem. 260 (1985) 6069^
6079.
[61] S.F. D’Souza, P.A. Srere, J. Biol. Chem. 258 (1983) 4706^
4709.
[62] J.K. Teller, L.A. Fahien, E. Valdivia, J. Biol. Chem. 265
(1990) 19486^19494.
BBAMEM 77926 22-9-00
P.M. Drown et al. / Biochimica et Biophysica Acta 1468 (2000) 273^284284
